Cutaneous adverse events following CAR T-cell therapy in hematologic malignancies. [PDF]
Umyarova E +8 more
europepmc +1 more source
CAR T cell therapy in autoantibody-mediated neurological disorders: a promising strategy. [PDF]
Wen M +10 more
europepmc +1 more source
Breakthroughs and challenges of CAR-T cell therapy in treating hematologic malignancies of the central nervous system. [PDF]
Li X +5 more
europepmc +1 more source
Obstacles and improvement strategies for CAR-T cell therapy in solid tumors. [PDF]
Luo Z +9 more
europepmc +1 more source
Editorial: Enhancing CAR T-cell therapy with imaging. [PDF]
Lopci E, de Jong D, Dercle L.
europepmc +1 more source
Combining Small-Molecular Compounds With CAR T-Cell Therapy: Novel Strategies for Enhanced Cancer Immunotherapy. [PDF]
Yi R, Zhang Z, Yang Y, Zhu H.
europepmc +1 more source
Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-Cell lymphoma [PDF]
Bartlett, N. L, et al,, Ghobadi, A.
core +1 more source
Nanoparticles-enhanced CAR-T cell therapy: current advances and future directions. [PDF]
Wang Z +14 more
europepmc +1 more source
AL amyloidosis: a real-world experience with CAR T-cell therapy. [PDF]
Tan MSY +23 more
europepmc +1 more source
CAR-T cell therapy: A new dawn in the treatment of autoimmune disease. [PDF]
Yan S, Zhu X, Xiao Y.
europepmc +1 more source

